Collegium to Participate in Upcoming Needham Healthcare Conference

STOUGHTON, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will participate in the following investor conference:

21st Annual Needham Virtual Healthcare ConferenceVirtual fireside chatDate: Wednesday, April 13, 2022

The fireside chat will be webcast and can be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event.

About Collegium Pharmaceutical, Inc.Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Contact:Alex DasallaHead of Investor Relations[email protected]

You May Also Be Interested In

• Solerus Announces Plans for New Growth Fund for High-Net-Worth Investors
• Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
• SuperiorMed Holdings Limited Announces Entering into an Agreement and Plan of Merger with Starry Sea Acquisition Corp